| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/25/2013 | US8471125 Plants and seeds of corn variety CV700979 |
| 06/25/2013 | US8471124 Plants and seeds of corn variety CV448967 |
| 06/25/2013 | US8471123 Plants and seeds of corn variety CV286014 |
| 06/25/2013 | US8471114 Tomato line PSQ24-2212 |
| 06/25/2013 | US8471099 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 06/25/2013 | US8470995 Enzymes involved in triterpene synthesis |
| 06/25/2013 | US8470990 Ribosome structure and protein synthesis inhibitors |
| 06/25/2013 | US8470981 Additives for the improved dewatering of corn gluten |
| 06/25/2013 | US8470973 Modular DNA-binding domains and methods of use |
| 06/25/2013 | US8470972 Nonviral vectors for delivering polynucleotides to plants |
| 06/25/2013 | US8470970 Mammalian sweet and amino acid heterodimeric taste receptors comprising T1R3 and T1R1 |
| 06/25/2013 | US8470969 Apo-2 ligand/trail formulations |
| 06/25/2013 | US8470965 Methods and compositions related to cyclic peptide synthesis |
| 06/25/2013 | US8470963 Multifunctional compounds for pharmaceutical purposes |
| 06/25/2013 | US8470826 Episomal fusion gene |
| 06/25/2013 | US8470782 Transglutaminase inhibitors and methods of use thereof |
| 06/25/2013 | US8470778 VIP fragments and methods of use |
| 06/25/2013 | US8470777 Pregnancy-induced oligodendrocyte precursor cell proliferation regulated by prolactin |
| 06/25/2013 | US8470769 Method of treatment of bacterial infection by administration of poly-lysine |
| 06/25/2013 | US8470768 Peptide epitopes of apolipoprotein B |
| 06/25/2013 | US8470764 Bacillus thuringiensis gene with coleopteran activity |
| 06/25/2013 | US8470607 Inhibition of angiogenesis |
| 06/25/2013 | US8470592 Isolation and characterization of Schizochytrium aggregatum cellobiohydrolase I (Cbh 1) |
| 06/25/2013 | US8470583 Lactobacillus strain and bacteriocin |
| 06/25/2013 | US8470580 Method for the selection of recombination clones comprising a sequence encoding an antidote protein to a toxic molecule |
| 06/25/2013 | US8470561 GPCR comprising an IC2 insertion |
| 06/25/2013 | US8470559 Growth hormone fusion proteins |
| 06/25/2013 | US8470557 Isolated nucleic acids encoding activated factor V and methods for production thereof |
| 06/25/2013 | US8470555 Protein substance having triple helix structure and manufacturing method therefor |
| 06/25/2013 | US8470554 Prokaryotic expression of soluble, active Dkk |
| 06/25/2013 | US8470545 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1) |
| 06/25/2013 | US8470543 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 06/25/2013 | US8470527 Method of inhibiting HIV-1 replication by administering modified GP41 C34 peptide derivatives with enhanced pharmacological properties |
| 06/25/2013 | US8470354 Osteogenic implants with combined implant materials and methods for same |
| 06/25/2013 | US8470341 Escherichia coli immunogens with improved solubility |
| 06/25/2013 | US8470334 Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics |
| 06/25/2013 | US8470332 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR |
| 06/25/2013 | US8470330 PSMA antibodies and uses thereof |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | CA2703490C Regulatory elements associated with cbf transcription factor of rye |
| 06/25/2013 | CA2653566C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 06/25/2013 | CA2513743C Reducing culling in herd animals growth hormone releasing hormone (ghrh) |
| 06/25/2013 | CA2513218C Peptides and uses thereof for preventing and treating alzheimer's disease(ad) |
| 06/25/2013 | CA2498886C Process for decreasing aggregate levels of pegylated protein |
| 06/25/2013 | CA2496422C Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 06/25/2013 | CA2492097C Signal for packaging of influenza virus vectors |
| 06/25/2013 | CA2482464C Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/25/2013 | CA2480217C G-type peptides to ameliorate atherosclerosis |
| 06/25/2013 | CA2454578C Modified human thymic stromal lymphopoietin |
| 06/25/2013 | CA2446110C A system for inducible expression in eukaryotic cells |
| 06/25/2013 | CA2407460C Targeted modification of chromatin structure |
| 06/25/2013 | CA2402718C Fish vaccine against piscirickettsia salmonis |
| 06/25/2013 | CA2366211C Hyphal growth in fungi |
| 06/25/2013 | CA2347849C Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 06/25/2013 | CA2328520C Use of anti-prolactin agents to treat proliferative conditions |
| 06/25/2013 | CA2214453C Novel avian cytokines and genetic sequences encoding same |
| 06/20/2013 | WO2013090919A1 Fgf-2 having enhanced stability |
| 06/20/2013 | WO2013089889A2 Chimeric polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/20/2013 | WO2013089550A1 Method for obtaining a dialyzable leukocyte extract |
| 06/20/2013 | WO2013089252A1 Modification of helper t cell-inducing polypeptide |
| 06/20/2013 | WO2013088920A1 Yeast having freezing stress resistance |
| 06/20/2013 | WO2013088371A2 Use of the mmp-12 protein in the prevention and/or treatment of dandruff conditions of the scalp |
| 06/20/2013 | WO2013088370A2 Use of the protein mmp-12 in the prevention and/or treatment of sensitive skin |
| 06/20/2013 | WO2013088369A2 Use of the protein mmp-12 in the prevention and/or treatment of greasy skin and/or greasy-prone skin |
| 06/20/2013 | WO2013088368A2 Use of the mmp-12 protein in the prevention and/or treatment of aged or senescent skin |
| 06/20/2013 | WO2013088147A1 Process for t cell expansion |
| 06/20/2013 | WO2013088141A1 Polypeptide comprising the sequence egpwleeeeeayg linked to an immunogenic carrier |
| 06/20/2013 | WO2013088136A1 Ligand for dngr-1 receptor |
| 06/20/2013 | WO2013088110A1 Annexin-a1 transgenic animals |
| 06/20/2013 | WO2013087922A1 Methods for producing engineered fluorescent proteins for enhanced fret, products and uses thereof |
| 06/20/2013 | WO2013087921A1 Engineered fluorescent proteins for enhanced fret and uses thereof |
| 06/20/2013 | WO2013087884A1 Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides |
| 06/20/2013 | WO2013087785A2 Bowman-birk protease inhibitor (bbi) binding peptides, and uses thereof in the separation, detection or purification of bbi |
| 06/20/2013 | WO2013087601A2 Polyomavirus peptide sequences |
| 06/20/2013 | WO2013086927A1 Human insulin analogue and acylated derivative thereof |
| 06/20/2013 | WO2013086786A1 Compound and composition having hypoglycemic effect and use thereof |
| 06/20/2013 | WO2013086785A1 Compound and composition having hypoglycemic effect and use thereof |
| 06/20/2013 | WO2013086636A1 Soluble igf receptor fc fusion proteins and uses thereof |
| 06/20/2013 | WO2013063556A4 Humanized il-6 and il-6 receptor |
| 06/20/2013 | WO2013062327A3 Ａｔｐｇ4 protein having productivity increase function, anti-aging function, stress resistance function of plants, genes thereof, and uses thereof |
| 06/20/2013 | WO2013053008A3 Molecules which bind clec9a |
| 06/20/2013 | WO2013052811A3 Affenadenorirus (gorilla) or adenoviral vectors and methods of use |
| 06/20/2013 | WO2013050529A3 Use of igf-1 in the stimulation of treg cell activity and the treatment autoimmune disorders |
| 06/20/2013 | WO2013045404A3 Inhibition of interleukin 1 beta for treating endometriosis |
| 06/20/2013 | WO2013038385A3 Escherichia coli vaccine combination |
| 06/20/2013 | WO2013022808A3 Immunogenic protein conjugates and methods for making and using the same |
| 06/20/2013 | WO2013012770A3 Process for producing recombinant human endostatin adenovirus |
| 06/20/2013 | US20130160166 Oral insulin therapy |
| 06/20/2013 | US20130160163 Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions |
| 06/20/2013 | US20130160159 Gemini virus replication inhibitor |
| 06/20/2013 | US20130160156 Method for down-regulating gene expression in fungi |
| 06/20/2013 | US20130158502 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 06/20/2013 | US20130158239 Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose |
| 06/20/2013 | US20130158235 Selective manufacture of recombinant neurotoxin polypeptides |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158233 Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism |
| 06/20/2013 | US20130157961 Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use |
| 06/20/2013 | US20130157953 Treatment of cardiac conditions |
| 06/20/2013 | US20130157948 Bispecific egfr/igfir binding molecules |
| 06/20/2013 | US20130157945 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof |